BSMMU gets proposal of third phase vaccine trial of Chinese firm

News Headline ::

Shakib Khan’s ‘Rajkumar’ to premiere on Bongo on 13 June Turkey opposes NATO takes part in Ukraine war Biden calls Trump ‘reckless’ BMD predicts light rain, thundershowers in Dhaka, other divisions PM asks youths to get knowledge to build a better Bangladesh Modi’s alliance to win big in India election, exit polls project 149 bhories of gold ornaments stolen from bank locker in Ctg Mexico on brink of electing first woman president Drama serial ‘Milon Hobe Kotodine’ Child marriage: A union that robs a girl of smile

Home

Dhaka Division

BSMMU gets proposal of third phase vaccine trial of Chinese firm

Shawdesh desk:

The authorities of Bangabandhu Sheikh Mujib Medical University (BSMMU) are mulling to approve third phase trial proposal of Chinese pharmaceutical company Anhui Zhifei’s Covid-19 vaccine.

The BSMMU received a letter from China’s Anhui Zhifei Longcom Biologic Pharmacy on Sunday. Earlier on September 2, it received the first letter, Prof Dr Kanak Kanti Barua, vice chancellor of BSMMU, confirmed the matter.

It should be mentioned here that another Chinese company ‘Sinovac Ltd’ backtracked from their proposal of conducting third phase trial of its vaccine with icddr,b in Bangladesh on the pretext of “fund shortage”.

In its proposal, the Anhui Zhifei, according to officials, said the company will bear the cost for the trial. Besides, it will take the initiative to set a vaccine production plant in Bangladesh if the vaccine passes the trial.